At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CURE Direxion Daily Healthcare Bull 3X ETF
Post-Mkt 11-03 18:29:29 EST
165.52
-1.25
-0.75%
盘后164.14
-1.38-0.83%
18:18 EST
High169.00Low164.18Vol57.78K
Open164.49D1 Closing166.77Amplitude2.89%
Mkt Cap198.63MTradable Cap198.63MTotal Shares1.20M
T/O9.60MT/O Rate4.81%Tradable Shares1.20M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Health Rounds: GLP-1 Drugs Help Control Prediabetes Better than Current Standard Medicine
Reuters  ·  05:22
Health Rounds: GLP-1 Drugs Help Control Prediabetes Better than Current Standard Medicine
Eli Lilly EVP, GC & Secretary Anat Hakim Reports Disposal of $7.01 Million in Common Shares
Reuters  ·  05:15
Eli Lilly EVP, GC & Secretary Anat Hakim Reports Disposal of $7.01 Million in Common Shares
EBR Systems Executives to Present at Canaccord MedTech Forum
TIPRANKS  ·  11-03 07:42
EBR Systems Executives to Present at Canaccord MedTech Forum
Eli Lilly & Co (LLY) Receives a Rating Update from a Top Analyst
TIPRANKS  ·  11-03 00:42
Eli Lilly & Co (LLY) Receives a Rating Update from a Top Analyst
3 Healthcare Stocks with ‘Strong Buy’ Analyst Ratings and ‘Perfect 10’ Smart Scores
TIPRANKS  ·  11-02 22:31
3 Healthcare Stocks with ‘Strong Buy’ Analyst Ratings and ‘Perfect 10’ Smart Scores
Eli Lilly price target raised to $1,600 from $1,440 at Cantor Fitzgerald
TIPRANKS  ·  11-02 21:16
Eli Lilly price target raised to $1,600 from $1,440 at Cantor Fitzgerald
BUZZ-US Stocks Weekly: Spooky
Reuters  ·  11-02 19:00
BUZZ-US Stocks Weekly: Spooky
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400
MT Newswires Live  ·  11-02 18:38
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400
Guerbet Continues Talks to Finalize Refinancing
TIPRANKS  ·  11-02 16:37
Guerbet Continues Talks to Finalize Refinancing
Eli Lilly : Berenberg Raises Target Price to $1570 from $1400
THOMSON REUTERS  ·  11-02 13:59
Eli Lilly : Berenberg Raises Target Price to $1570 from $1400
Affordable Care Act Rates to Rise Steeply-Again
Dow Jones  ·  10-31
Affordable Care Act Rates to Rise Steeply-Again
The Big Winners of the Tech Wreck are Biopharma Stocks
Dow Jones  ·  10-31
The Big Winners of the Tech Wreck are Biopharma Stocks
Eli Lilly Seen Sustaining Obesity Growth, UBS Says
MT Newswires Live  ·  10-31
Eli Lilly Seen Sustaining Obesity Growth, UBS Says
Eli Lilly's GLP-1 Penetration, Volume Seen in Early Stages, RBC Capital Markets Says
MT Newswires Live  ·  10-31
Eli Lilly's GLP-1 Penetration, Volume Seen in Early Stages, RBC Capital Markets Says
Eli Lilly Price Target Raised to $1550.00/Share from $1300.00 by Argus Research
Dow Jones  ·  10-30
Eli Lilly Price Target Raised to $1550.00/Share from $1300.00 by Argus Research
Eli Lilly price target raised to $1,500 from $1,330 at Wells Fargo
TIPRANKS  ·  10-30
Eli Lilly price target raised to $1,500 from $1,330 at Wells Fargo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tenet Healthcare (THC), Eli Lilly & Co (LLY) and DaVita (DVA)
TIPRANKS  ·  10-30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tenet Healthcare (THC), Eli Lilly & Co (LLY) and DaVita (DVA)
Eli Lilly & Co. : Morgan Stanley Raises Target Price to $1596.00 from $1430.00
THOMSON REUTERS  ·  10-30
Eli Lilly & Co. : Morgan Stanley Raises Target Price to $1596.00 from $1430.00
Eli Lilly : Scotiabank Raises Target Price to $1605 from $1300
THOMSON REUTERS  ·  10-30
Eli Lilly : Scotiabank Raises Target Price to $1605 from $1300
LLY Stock Hits Record as CEO Says Middle-Income Consumers Are Driving Pharma’s ‘Largest New Category Expansion’
Benzinga Earnings  ·  10-30
LLY Stock Hits Record as CEO Says Middle-Income Consumers Are Driving Pharma’s ‘Largest New Category Expansion’

Introduction

Company Name.
Direxion Daily Healthcare Bull 3X ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Issue price:
--